Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Oct-Dec;20(4):165-9.
doi: 10.4103/0971-9261.154664.

Non-rhabdomyosarcoma soft-tissue sarcomas in children: Contemporary appraisal and experience from a single centre

Affiliations
Review

Non-rhabdomyosarcoma soft-tissue sarcomas in children: Contemporary appraisal and experience from a single centre

Sajid S Qureshi et al. J Indian Assoc Pediatr Surg. 2015 Oct-Dec.

Abstract

Nonrhabdmyosarcoma soft tissue sarcomas (NRSTS) include a cluster of different types of soft tissue sarcomas clubbed together due to the rarity of individual subtypes. The diagnostic accuracy is lately reinforced due to the availability of immunohistochemical and molecular markers. Surgery is the central modality of treatment since many of them are insensitive to chemotherapy. With the availability of rational risk stratification system, efforts are in progress to evaluate the role of neoadjuvant chemotherapy and radiotherapy to improve outcomes especially for the locally advanced disease. The survival remains dismal for metastatic disease. This review highlights the current status of NRSTS and also describes the experience from a single centre in treatment of NRSTS.

Keywords: Children; non-rhabdomyosarcoma; soft-tissue sarcoma.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

References

    1. Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR. Soft Tissue Sarcomas. In: Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, editors. Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995, National Cancer Institute, SEER Program. NIH Pub. No. 99-4649. Bethesda, Maryland: 1999. pp. 111–24.
    1. Spunt SL, Hill DA, Motosue AM, Billups CA, Cain AM, Rao BN, et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcoma. J Clin Oncol. 2002;20:3225–35. - PubMed
    1. Spunt SL, Poquette CA, Hurt YS, Cain AM, Rao BN, Merchant TE, et al. Prognostic factors for children and adolescents with surgically resected non-rhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3697–705. - PubMed
    1. Pappo AS, Rao BN, Jenkins JJ, Merchant TE, Poquette CA, Cain AM, et al. Metastatic nonrhabdomyosarcomatous soft-tissue sarcomas in children and adolescents: The St Jude Children's Research Hospital experience. Med Pediatr Oncol. 1999;33:76–82. - PubMed
    1. Pratt CB, Maurer HM, Gieser P, Salzberg A, Rao BN, Parham D, et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A Pediatric Oncology Group study. Med Pediatr Oncol. 1998;30:201–9. - PubMed